slides · global inventory
Paragraph
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 118,578
Current window 92,431-92,460
Pages 3,953
Rows per page 30
Component
92,431-92,460 of 118,578
06
Compass Therapeutics | Investor Presentation Deck | 23 slidesCompass Therapeutics | Investor Presentation Deck | 23 slides · Compass Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
09
Uses the Simon 2-Stage adaptive design framework.Compass Therapeutics | Investor Presentation Deck | 23 slides · Compass Therapeutics
Pitch deck Investor relations Beat · ProductLoop · Cost Of Inaction1 hit
11
The chart uses a standard oncology waterfall plot format to visualize tumor shrinkage.Compass Therapeutics | Investor Presentation Deck | 23 slides · Compass Therapeutics
Pitch deck Investor relations Beat · ProductLoop · Cost Of Inaction1 hit
16
Compass Therapeutics | Investor Presentation Deck | 23 slidesCompass Therapeutics | Investor Presentation Deck | 23 slides · Compass Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
17
Includes a molecular visualization of the antibody-receptor interaction.Compass Therapeutics | Investor Presentation Deck | 23 slides · Compass Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
20
Compass Therapeutics | Investor Presentation Deck | 23 slidesCompass Therapeutics | Investor Presentation Deck | 23 slides · Compass Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
21
The slide uses a process flow to show the transition from testing a hypothesis to the identification of the lead candidate CTX-8371, supported by two experimental charts.Compass Therapeutics | Investor Presentation Deck | 23 slides · Compass Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
03
Compass Therapeutics | Investor Presentation Deck | 36 slidesCompass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations 1 hit
11
Includes list of authors and their institutional affiliations.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · Problem1 hit
12
Clinical trial schema showing randomization of 685 patients into Durvalumab+GemCis or Placebo+GemCis arms.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · Problem1 hit
13
Clinical trial data presented at ASCO GI22.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · Problem1 hit
14
Clinical trial data presented at ASCO GI 2022.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · Problem1 hit
17
The slide highlights the limited progression-free survival (PFS) with a red box around the PFS column.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
22
The slide includes a 'Number at risk' table below the chart, which is standard for clinical trial survival analysis.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
27
The plot displays individual patient responses categorized by cancer type (Gastric, CRC, Cholangio, Pancreatic, Other).Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
28
Includes footnotes explaining context for hypertension and cytopenia events compared to standard chemotherapy agents.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
29
Uses a Simon 2-stage adaptive design.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
32
Standard oncology waterfall plot showing individual patient response to treatment.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
01
Crocs | Results Presentation Deck | 33 slidesCrocs | Results Presentation Deck | 33 slides · Crocs
Conference presentation Investor relations Beat · Problem1 hit
07
Crocs | Results Presentation Deck | 33 slidesCrocs | Results Presentation Deck | 33 slides · Crocs
Conference presentation Investor relations Loop · Logic Chain1 hit
24
Includes footnotes explaining specific adjustments for distribution centers, HEYDUDE acquisition, and Russia operations.Crocs | Results Presentation Deck | 33 slides · Crocs
Conference presentation Investor relations 1 hit
26
Includes footnotes referencing prior reconciliation details.Crocs | Results Presentation Deck | 33 slides · Crocs
Conference presentation Investor relations 1 hit
28
The slide provides a detailed breakdown of the numerator (net income adjustments) and denominator (weighted average shares) to arrive at Non-GAAP EPS.Crocs | Results Presentation Deck | 33 slides · Crocs
Conference presentation Investor relations 1 hit
29
Includes detailed footnotes explaining the nature of the adjustments related to the HEYDUDE acquisition and IP amortization.Crocs | Results Presentation Deck | 33 slides · Crocs
Conference presentation Investor relations 1 hit
31
The table reconciles GAAP to Non-GAAP SG&A expenses for the three months ended March 31, 2022 and 2021.Crocs | Results Presentation Deck | 33 slides · Crocs
Conference presentation Investor relations 1 hit
01
Cyxtera | Results Presentation Deck | 22 slidesCyxtera | Results Presentation Deck | 22 slides · Cyxtera
Conference presentation Investor relations Beat · Attention1 hit
01
D-Wave | SPAC Presentation Deck | 38 slidesD-Wave | SPAC Presentation Deck | 38 slides · D-Wave
Pitch deck Investment bank 1 hit
04
Standard legal risk disclosure slide for an investor presentation.D-Wave | SPAC Presentation Deck | 38 slides · D-Wave
Pitch deck Investment bank 1 hit
05
D-Wave | SPAC Presentation Deck | 38 slidesD-Wave | SPAC Presentation Deck | 38 slides · D-Wave
Pitch deck Investment bank 1 hit
06
The slide highlights the SPAC's leadership and their pedigree through logos of companies they have been associated with.D-Wave | SPAC Presentation Deck | 38 slides · D-Wave
Pitch deck Investment bank Beat · Team1 hit